Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1385818 · FYE Jun 30 · Prices AT CLOSE 2026-08-19 (USD) Last $2.36 · Day +0.00% · Mkt cap $25M · 1Y +7.3% · Off 52W high −23.0% · Vol (1Y) 52.9% Price2023-08-21 → 2026-08-19 AYTU close: $1.69 on 2023-08-21 to $2.36 on 2026-08-19. Split-adj closes · 240 of 2,388 · price returnⓘ At a glance | Short interest3.0% of sh out | | Days to cover12.5d | | 13F net flow (QoQ)+0.64% | | Top-10 13F concentration93.7% | | Next report (est.)2026-11-11 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$56.6M | | Earnings (TTM)-$34.1M | | ROE−58.1% | | Net margin−20.4% | | ROIC−58.3% | | Debt / equity0.67× | | Sales growth 3Y−11.8% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−9.2% | | 1Y+7.3% | | 3Y+39.6% | | 5Y−96.5% | | Since incept. (ann.)−66.5% |
Total return · from 2017-02-01ⓘ Risk | Ann. volatility (1Y)52.9% | | Ann. volatility (3Y)85.4% | | Sharpe (1Y)0.40 | | Sharpe (3Y)0.49 | | Max drawdown (1Y)−31.9% | | Max drawdown (3Y)−70.2% | | Beta (3Y vs SPY)−0.46 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Nantahala Capital Management, LLC | 1.1M | $3M | 10.13% | +0.0% | | Stonepine Capital Management, LLC | 792,289 | $2M | 7.38% | −2.6% | | AWM Investment Company, Inc. | 619,574 | $2M | 5.77% | +0.0% | | DIADEMA PARTNERS LP | 353,077 | $963,900 | 3.29% | +15.5% | | VANGUARD CAPITAL MANAGEMENT LLC | 261,146 | $712,929 | 2.43% | new | | CROWN ADVISORS MANAGEMENT, INC. | 145,000 | $395,000 | 1.35% | new | | TWO SIGMA INVESTMENTS, LP | 121,973 | $332,986 | 1.14% | +13.9% | | RENAISSANCE TECHNOLOGIES LLC | 93,723 | $255,864 | 0.87% | +4.6% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-05-13 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-03-31 | 2026-05-13 | −$0.53 | −352.4% | $12.4M | −32.7% | | 2025-12-31 | 2026-02-03 | −$1.05 | — | $15.2M | −6.5% | | 2025-09-30 | 2025-11-13 | −$0.08 | — | $13.9M | −16.2% | | 2025-06-30 | 2025-09-23 | — | — | $15.1M | +3.7% |
As-reported XBRL · next 2026-11-11 est.ⓘ Segment mixFY2025 (ended Jun 2025) Rx 100% business · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
